These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33512002)

  • 1. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
    Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women.
    Mchome BL; Kjaer SK; Manongi R; Swai P; Waldstroem M; Iftner T; Wu C; Mwaiselage J; Rasch V
    Sex Transm Infect; 2021 Feb; 97(1):56-62. PubMed ID: 32269071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya.
    Guthrie BL; Rositch AF; Cooper JA; Farquhar C; Bosire R; Choi R; Kiarie J; Smith JS
    Sex Transm Infect; 2020 Sep; 96(6):457-463. PubMed ID: 31919275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
    ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
    Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
    Baldur-Felskov B; Mwaiselage J; Faber MT; Kjaerem M; de la Cour CD; Munk C; Kahesa C; Iftner T; Rasch V; Kjaer SK
    Trop Med Int Health; 2019 Feb; 24(2):229-237. PubMed ID: 30444556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.
    Dartell M; Rasch V; Munk C; Kahesa C; Mwaiselage J; Iftner T; Kjaer SK
    Sex Transm Dis; 2013 Sep; 40(9):737-43. PubMed ID: 23949589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.
    Musa J; Taiwo B; Achenbach C; Olugbenga S; Berzins B; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
    Arch Gynecol Obstet; 2013 Dec; 288(6):1365-70. PubMed ID: 23700253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk papillomavirus infection among women living with human Immunodeficiency virus: Brazilian multicentric study.
    Miranda AE; Silveira MF; Travassos AG; Tenório T; Val ICC; Lannoy L; Mattos Junior HS; Carvalho NS
    J Med Virol; 2017 Dec; 89(12):2217-2223. PubMed ID: 28771777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk human papillomavirus infection and abnormal cervical cytology among Nepali and Bhutanese refugee women living in eastern Nepal.
    Bhatta MP; Johnson DC; Lama M; Aryal S; Lhaki P; Shrestha S
    BMC Infect Dis; 2017 Jan; 17(1):73. PubMed ID: 28088173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
    BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
    Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
    J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Cervical Cancer Prevention in Tanzania (CONCEPT) study: Cohort profile.
    Mchome B; Swai P; Wu C; Katanga J; Kahesa C; Manongi R; Mwaiselage JD; Kjaer S; Rasch V; Linde DS
    BMJ Open; 2020 Sep; 10(9):e038531. PubMed ID: 32948569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening.
    Lazenby GB; Taylor PT; Badman BS; McHaki E; Korte JE; Soper DE; Young Pierce J
    Clin Ther; 2014 Jan; 36(1):38-45. PubMed ID: 24417784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.
    Dartell M; Rasch V; Kahesa C; Mwaiselage J; Ngoma T; Junge J; Gernow A; Ejlersen SF; Munk C; Iftner T; Kjaer SK
    Sex Transm Dis; 2012 Mar; 39(3):201-8. PubMed ID: 22337107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women.
    Ortiz AP; Tamayo V; Scorsone A; Soto-Salgado M; Febo I; Piovanetti P; Venegas-Ríos HL; Yamamura Y; Zorrilla C
    Papillomavirus Res; 2017 Dec; 4():39-44. PubMed ID: 29179868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence rate of cervical human papillomavirus infections and abnormal cytology in Rwanda.
    Mukanyangezi MF; Rugwizangoga B; Manzi O; Rulisa S; Hellstrand K; Tobin G; Martner A; Bienvenu E; Giglio D
    HIV Med; 2019 Aug; 20(7):485-495. PubMed ID: 31318136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.